The impact of medical specialist involvement in the provision of ambulatory care for patients with chronic diseases (CDs) may vary depending on the role taken by the specialist (co-manager vs. consultant). Specialists are involved as co-managers when they act as regular care providers in the management of their patients, sharing responsibilities with the primary care physician (PCP) for long-term follow-up of the referred health problem ([@R14]). On the other hand, specialists are involved as consultants when their role is limited to providing diagnostic/ management advice to PCPs or performing diagnostic/curative technical interventions without providing ongoing management for the health problem ([@R14]). For example, in the case of consultation, a PCP could refer a patient with knee osteoarthritis to the orthopaedist for an injection. Once the intervention would be completed, the patient would return to the PCP for follow-up and would only return to see an orthopaedist when further advice or intervention would be sought. In the case of co-management, the patient would return regularly to the orthopaedist for monitoring of his arthritis and adjustment of the treatment plan. The patient would still be attended by the PCP for management of other health needs.

Patients with CDs are often frequent users of emergency departments (EDs), and most of their direct costs are actually attributed to ED and hospital admissions ([@R1]; [@R7]; [@R26]). This is mainly due to exacerbations/complications of their conditions requiring rapid access to advanced care; they also use the ED as an alternate source of primary care for their conditions when access to a PCP is limited ([@R19]; [@R31]; [@R36]). In fact, for patients with CDs living in the community, ED use is considered a sensitive indicator of quality and efficacy of ambulatory care, especially for congestive heart failure (CHF), chronic obstructive pulmonary disease (COPD) or diabetes, as a significant proportion of ED visits and hospitalizations could be prevented by proper ambulatory care ([@R19]; [@R28]; [@R31]; [@R35]; [@R36]). However, little is known regarding the impact of specialist involvement in the ambulatory care of patients with CDs on ED use. Furthermore, it is not known whether co-management is superior to consultation with respect to preventing ED use. Such information is needed to improve CD management and consequently reduce adverse events leading to preventable ED visits for patients, as well as to decrease consequent healthcare costs and ED overcrowding/wait times for the whole healthcare system ([@R8]). Therefore, our objective was to determine the impact of the type of specialist involvement on all-cause ED use for patients with CDs managed in the primary care setting.

Methods
=======

Design, recruitment and data collection
---------------------------------------

We followed a cohort of adults with CDs living in the Montreal and Montérégie regions of Quebec (Canada) between 2006 and 2008 ([@R13]; [@R25]). Out of the 675 primary care organizations found in these regions ([@R17]), we contacted 90 primary healthcare practices providing services for patients with CDs, representing all types of primary healthcare practice arrangements (solo, Conventional group practices, Family Medicine Groups, Community health centres and Hospital-based family medicine units) and having at least four PCPs when being a group practice. In total, 33 primary healthcare practices referred 1,031 patients with diabetes, arthritis, CHF or COPD, of whom 776 provided written informed consent and entered the cohort. Patients were interviewed at baseline and subsequently at 6, 12 and 18 months using standardized questionnaires regarding socio-demographic/clinical characteristics, utilization and quality of care, as well as health and quality-of-life outcomes. We also linked patient data from the provincial physician reimbursement administrative database, including information over the period of 12 months prior to entry into the study until 12 months after entry. The entire population of Quebec is covered by provincial health insurance, and physicians bill the province for ambulatory services rendered to patients. A referral by a physician is usually required to consult a specialist physician, as there are financial incentives for specialists delivering services with a referral.

Specialist involvement
----------------------

Specialist involvement was determined using the physician reimbursement database and was defined as having at least one outpatient (ED excluded) encounter with a relevant specialist in the 12 months prior to entry in the study. Relevant specialists considered for each diagnosis were cardiologist for CHF, respirologist for COPD, endocrinologist for diabetes and rheumatologist or orthopaedist for arthritis. Patients with specialist involvement were further classified according to the type of involvement using the following question at baseline: *Which clinic mainly follows you for your (diagnosis)? (a) your primary care clinic, where your general practitioner is; or (b) your specialized clinic, where your specialist doctor is*. Those answering (*b*) were classified as being co-managed by a specialist. For those who answered (*a*), we used a second question asked at the 18-month follow-up to further determine the type of involvement: *In addition to being followed by a general practitioner for your (diagnosis), are you also followed by a specialist doctor? If yes, for how many years have you been followed by the specialist?* Participants who reported being followed by a specialist for at least two years were classified as being co-managed at entry into the study. All remaining participants were not considered as being co-managed -- any previous contact with a specialist was considered to be on a consultant basis.

Covariates
----------

Age, gender, highest level of education completed, area of residency (Montreal = urban, Montérégie = rural), co-morbidity and disease-specific health-related quality of life (HRQoL) were measured ([@R13]). Co-morbidity level was measured by the number of reported conditions from a list of 17 common CDs. We used disease-specific HRQoL as a proxy for disease severity, using the following tools: Health Assessment Questionnaire (HAQ) for arthritis ([@R6]; [@R29]), the Minnesota Living with Heart Failure ([@R15]; [@R40]), the Chronic Respiratory Questionnaire for COPD ([@R22]; [@R37]) and the Audit of diabetes-dependant quality of life (ADDQoL) ([@R5]). Scores were standardized on a common scale with a mean of 50 and a standard deviation (SD) of 10 ([@R42]), with lower scores representing less HRQoL (more severe cases). We also computed the number of outpatient physician encounters (ED excluded) in the previous 12 months using the physician reimbursement administrative database. For patients followed in community health centres or hospital-based family medicine units where PCPs are salaried instead of being paid on a fee-for-services basis, we added their self-reported number of PCP visits in the preceding year to those captured by the administrative database. We also estimated experience of PCP based on graduation year of the physician, using administrative data from the Quebec College of Physicians (licensing board).

Emergency department utilization
--------------------------------

We used the physician reimbursement database to record all-cause ED admissions (regardless of subsequent hospitalization or not) over the 12 months following entry into the study. Patients were classified as ED users if they had at least one ED admission during the follow-up period.

Statistical analyses
--------------------

Chi-square and Kruskall--Wallis tests were used to compare patient characteristics according to type of specialist involvement (none, consultant or co-manager). Crude rates and crude odds ratios (ORs) of ED use according to type of specialist involvement were computed along with their 95% confidence intervals (95% CI) across each diagnosis. Adjusted ORs of ED use according to type of specialist involvement were estimated with simple multivariate logistic regression models instead of multilevel ones, as exploratory analyses indicated that despite our nested sampling design, there was no clustering at practice level. Diagnosis, co-morbidity, HRQoL, physician outpatient visits, age, gender, education, area of residency and experience of PCP were entered to adjust for case mix. Experience of PCP was kept only if it modified ORs significantly (change ≥5%). Interaction of the type of specialist involvement with diagnosis was further tested by adding a product term and using the likelihood ratio test. Data were analyzed using SPSS 15.0 (IBM, Chicago). The study was approved by the research ethics committees of the relevant institutions.

Results
=======

Out of the 776 patients who consented, 709 had complete data, which were used for analyses. There were no significant differences between participants and non-participants according to diagnosis, gender and age (results not shown). The majority of participants were at least 65 years old (54.2%, minimum = 22, maximum = 97) and had at least one co-morbidity (74.8%, minimum = 0, maximum = 13) (Table [1](#T1){ref-type="table"}).

###### 

Characteristics of participants according to type of specialist involvement (*N* = 709)

  Characteristics                                             Overall[\*](#TFN1-1){ref-type="table-fn"} (*N* = 709)   Type of Specialist Involvement[\*](#TFN1-1){ref-type="table-fn"}   Difference Between Types (*p*-value)                  
  ----------------------------------------------------------- ------------------------------------------------------- ------------------------------------------------------------------ -------------------------------------- -------------- --------------------------------------------
  Diabetes                                                    34.6                                                    44.2                                                               20.3                                   14.0           \<0.001[^¶^](#TFN1-3){ref-type="table-fn"}
  Congestive heart failure                                    19.4                                                    12.1                                                               28.4                                   37.2           
  Chronic arthritis                                           26.8                                                    24.2                                                               39.2                                   27.4           
  COPD                                                        19.3                                                    19.5                                                               12.2                                   21.3           
  Co-morbidity, Median (IQR) count                            3.0 (1--4)                                              3.0 (1--4)                                                         3.0 (2--5)                             3.0 (2--5)     0.017[^§^](#TFN1-2){ref-type="table-fn"}
  HRQoL, Mean (SD) score                                      50.1 (9.9)                                              50.4 (10.2)                                                        50.9 (8.6)                             48.3 (9.9)     0.043[^§^](#TFN1-2){ref-type="table-fn"}
  Ambulatory physician utilization, Median (IQR) encounters   9.0 (6--15)                                             8.0 (5--12)                                                        14.0 (9--19)                           13.0 (8--20)   \<0.001[^¶^](#TFN1-3){ref-type="table-fn"}
  Female                                                      54.8                                                    54.6                                                               50.0                                   56.7           0.630
  Male                                                        45.2                                                    45.4                                                               50.0                                   43.3           
  Age, Mean (SD) years                                        66.9 (11.7)                                             66.5 (12.0)                                                        69.3 (10.9)                            67.1 (11.1)    0.164
  Education \< High school                                    47.6                                                    48.8                                                               50.0                                   42.1           0.159
  High school/vocational diploma                              28.5                                                    29.7                                                               28.4                                   26.8           
  Education \> High school                                    23.9                                                    21.4                                                               21.6                                   31.1           
  Urban area of residency                                     58.9                                                    51.8                                                               64.9                                   75.0           \<0.001[^¶^](#TFN1-3){ref-type="table-fn"}
  Rural area of residency                                     41.1                                                    48.2                                                               35.1                                   25.0           
  Experience of PCP, Mean (SD) years                          27.2 (8.5)                                              27.0 (8.3)                                                         27.2 (8.9)                             27.7 ( 8.9)    0.686

Values are in % unless otherwise indicated.

Patients with specialist co-management are significantly different from non-users (*p* \< 0.05).

Both groups with specialist involvement are significantly different from non-users (*p* \< 0.05). COPD = chronic obstructive pulmonary disease; IQR = interquartile range; SD = standard deviation; HRQoL = health-related quality of life.

At baseline, 238 patients (33.6%) had at least one visit to a relevant specialist in the preceding year (median = 2.0 visits, minimum = 1, maximum = 21). Of these, 164 (68.9%) were co-managed and 74 others were classified as having visited the specialist on a consultation basis. The number of visits to the specialist in the previous year was higher for those who were co-managed (median = 2.0, interquartile range \[IQR\] = 1--4) than for those with consultation (median = 2.0, IQR = 1--3, *p* = 0.047). Patients with CHF were more likely to be co-managed as were those who lived in an urban area, had lower HRQoL and more co-morbidities (Table [1](#T1){ref-type="table"}).

There were 240 patients (34%) with at least one admission to the ED during the 12-month follow-up period (median = 1.0 visit, IQR = 1--2, maximum = 18). ED use varied across diseases (Table [2](#T2){ref-type="table"}, *p* \< 0.001), with CHF and COPD patients having higher rates than those with arthritis or diabetes. This pattern was not present in the sub-sample of patients with specialist involvement either as co-manager (*p* = 0.962) or consultant (*p* = 0.406).

###### 

Rates in percentage of all-cause emergency department use according to type of specialist involvement and main diagnosis

  Type of Specialist Involvement   Main Diagnosis      Difference Across Diagnoses (*p*-value)                                           
  -------------------------------- ------------------- ----------------------------------------- ------------------- ------------------- ---------
  None (*n* = 471)                 21.1 (13.6, 28.5)   25.0 (19.1, 30.9)                         42.1 (29.3, 54.9)   47.8 (37.6, 58.0)   \<0.001
  Consultant (*n* = 74)            34.5 (17.2, 51.8)   26.7 (4.3, 49.0)                          52.4 (31.0, 73.7)   44.4 (12.0, 76.9)   0.406
  Co-manager (*n* = 164)           40.0 (25.7, 54.3)   39.1 (19.2, 59.1)                         44.3 (31.8, 56.7)   42.9 (26.5, 59.3)   0.962
  Overall (*n* = 709)              27.7 (21.3, 34.1)   26.4 (20.9, 31.9)                         44.6 (36.3, 52.9)   46.3 (37.9, 54.7)   \<0.001

CHF = congestive heart failure; COPD = chronic obstructive pulmonary disease; 95% CI = 95% confidence interval.

Co-managed patients had higher odds of visiting the ED than those who did not see a specialist (crude odds ratio \[OR\] = 1.65, 95% CI = \[1.14, 2.38\], Table [3](#T3){ref-type="table"}). Patients with specialist involvement as a consultant presented a similar trend (crude OR = 1.46, 95% CI = \[0.88, 2.43\]). Crude ORs did not vary across diagnoses for co-management (*p* = 0.168) or for specialist involvement as a consultant (*p* = 0.750).

###### 

Crude odds ratios of all-cause emergency department use according to type of specialist involvement and main diagnosis

  Main Diagnosis   Type of Specialist Involvement[\*](#TFN3-1){ref-type="table-fn"}   
  ---------------- ------------------------------------------------------------------ -----------------------
  Arthritis        1.97 (0.81, 4.80)                                                  **2.50 (1.18, 5.28)**
  Diabetes         1.09 (0.33, 3.57)                                                  1.93 (0.79, 4.72)
  CHF              1.51 (0.55, 4.13)                                                  1.09 (0.53, 2.26)
  COPD             0.87 (0.22, 3.46)                                                  0.82 (0.37, 1.79)
  Overall          1.46 (0.88, 2.43)                                                  **1.65 (1.14, 2.38)**

The reference category is no specialist involvement.

Bold = ratio differs significantly from 1.00 (*p* \< 0.05). OR = odds ratio; 95% CI = 95% confidence interval; CHF = congestive heart failure; COPD = chronic obstructive pulmonary disease.

Multivariate analyses indicated that patients with specialist involvement as a consultant (adjusted OR = 1.06, 95% CI = \[0.61, 1.85\]) or a co-manager (adjusted OR = 0.97, 95% CI = \[0.63, 1.50\]) were not more or less likely to visit the ED than those who had no contact with a specialist (Table [4](#T4){ref-type="table"}). We constructed a regression model that included interaction of specialist involvement and primary diagnosis. Because the impact of either co-management or consultation on ED use was similar, we calculated the model with a binary-level independent variable of any specialist involvement versus no contact with a specialist. We found a significant interaction of specialist involvement with diagnosis (*p* = 0.03) and proceeded to perform stratified analyses. For patients with COPD, specialist involvement tended to have a protective effect on ED admission (adjusted OR = 0.47, 95% CI = \[0.19, 1.20\]), whereas for arthritis (adjusted OR = 1.94, 95% CI = \[0.91, 4.16\]) and patients with diabetes (adjusted OR = 1.30, 95% CI = \[0.55, 3.08\]), it tended to have a detrimental one. There was no effect for patients with CHF (adjusted OR = 1.10, 95% CI = \[0.48, 2.55\]).

###### 

Results of multivariate logistic regression analyses of the impact of the type of specialist involvement on annual all-cause emergency department use in patients with chronic diseases (*N* = 709)

  Predictors[\*](#TFN4-1){ref-type="table-fn"}                     Levels          Adjusted OR   95% CI
  ---------------------------------------------------------------- --------------- ------------- ------------
  Specialist involvement                                           None            1             --
  Co-manager                                                       0.97            0.63, 1.50    
  Consultant                                                       1.06            0.61, 1.85    
  Diagnosis[^§^](#TFN4-2){ref-type="table-fn"}                     Arthritis       1             --
  CHF                                                              1.94            1.17, 3.20    
  Diabetes                                                         1.12            0.71, 1.77    
  COPD                                                             2.35            1.45, 3.81    
  Number of co-morbidities                                         0--1            1             --
  2--3                                                             1.32            0.84, 2.06    
  ≥4                                                               1.60            1.01, 2.55    
  HRQoL[^§^](#TFN4-2){ref-type="table-fn"}                         --              0.97          0.95, 0.99
  Number of ambulatory visits[^§^](#TFN4-2){ref-type="table-fn"}   --              1.04          1.02, 1.07
  Gender                                                           Male            1             --
  Female                                                           1.05            0.75, 1.49    
  Age (years)                                                      ≤63             1             --
  64--73                                                           0.83            0.55, 1.30    
  ≥74                                                              1.18            0.77, 1.80    
  Education level                                                  \<High school   1             --
  High school                                                      0.79            0.53, 1.18    
  \>High school                                                    0.90            0.58, 1.38    
  Area of residence[^§^](#TFN4-2){ref-type="table-fn"}             Urban           1             --
  Rural                                                            0.67            0.47, 0.96    

Experience of PCP is not included in the model, as it did not modify estimates.

*p* \< 0.05.

OR = odds ratio; 95% CI = 95% confidence interval; CHF = congestive heart failure; COPD = chronic obstructive pulmonary disease; HRQoL = health-related quality of life.

Discussion
==========

We found that the type of specialist involvement (co-management or consultant) did not have a differential effect on all-cause ED use for patients with CDs who were managed in the primary care setting. However, we found that impact of specialist involvement (irrespective of specialist\'s role) on all-cause ED use varied across diagnoses, with a tendency to have a protective effect only for patients with COPD.

We expected that co-management would present a greater advantage regarding optimizing treatment plans and possibly reducing ED visits; however, this hypothesis was not corroborated. Although co-management implies that both the specialist and the PCP share responsibility for patient management ([@R14]), it does not necessarily imply shared care, i.e., formalized collaboration between providers ([@R39]). We had no information regarding the quality of primary--specialty care coordination, which may explain the present findings. Another possible explanation is that our patients, recruited in primary care settings, were actively followed by their PCP who was, for the most part, capable of managing the condition appropriately on their own. Several authors contend that for conditions frequently encountered in the primary care setting, patients should be followed by their PCP and specialist involvement should be on a consultation basis only (i.e., not as a co-manager) ([@R14]; [@R20]; [@R34]; [@R41]). Our results support this notion. Specialist involvement as a consultant (associated with fewer visits to the specialist) could potentially free up some valuable time for the specialist to see more patients ([@R43]).

Irrespective of the type of involvement, respirologist utilization showed a trend (although non significant) towards reduced risk of ED admission for patients with COPD. This is consistent with decreased mortality observed with respirologist involvement ([@R33]) and may be due to higher conformity to guidelines and use of the most up-to-date management approaches often associated with specialist involvement ([@R3]; [@R10]; [@R16]; [@R38]; [@R45]). We did not find reduction in ED visits for patients with CHF who had contact with a cardiolo-gist in our sample, which contrasts with results in the literature ([@R12]; [@R24]). A possible explanation is that our participants were not recruited following ED or hospital admission for CHF (unlike those in the other studies) and may, therefore, be less apt to profit from cardiologist involvement, which would particularly benefit more severe cases ([@R2]). Surprisingly, specialist involvement tended to be associated with increased ED use in patients with diabetes and arthritis. Although endocrinologist/ diabetologist involvement prevents diabetic-specific complications (e.g., ketoacidosis or retinopathy) ([@R4]; [@R27]; [@R46]), all-cause mortality was found to increase with endocrinologist involvement ([@R30]). It is possible that involvement of the specialist could unintentionally increase fragmentation of care, contributing to higher use of ED for all causes ([@R28]; [@R30]). Fragmentation of care may have a greater impact on all-cause ED use for patients with diabetes and arthritis in which co-morbidities (rather than the disease itself) usually account for more morbidity and mortality than in patients with CHF and COPD ([@R11]; [@R18]; [@R32]).

Strengths and limitations
-------------------------

Strengths of our study include having information from physicians on patient diagnosis; patient-reported information regarding socioeconomics, co-morbidities, HRQoL and services use; and administrative data on utilization of services. To the best of our knowledge, this is the first study to consider the role of specialists in terms of consultant or co-manager and its association with ED use in patients with CDs. Although we were able to control for many potential confounders and to use multiple sources of data to minimize measurement errors, some limitations need to be addressed. We did not have either clinical or physiologic indicators of illness severity to adjust for case mix. Though proxies were used (HRQoL and number of ambulatory visits), there may be residual confounding by indication. A co-morbidity index considering severity of co-morbidities (e.g., Charlson Co-morbidity Index) would have adjusted for case-mix in terms of burden of disease ([@R9]; [@R44]). However, our data were less compatible with these types of indices for a third of our sample followed in community health centres or hospital-based family medicine units, where PCPs are salaried instead of being paid on a fee-for-services basis, and we, therefore, opted for disease count. Nevertheless, sensitivity analyses using the Johns Hopkins ACG System (Johns Hopkins University, Baltimore), which captures disease burden, yielded similar results (not shown) in a sub-sample of participants with compatible data. Our participation rates were relatively low for both practices (37%) and patients (68%). Although we cannot completely exclude a selection bias, participating practices did not differ from non-participating ones regarding type of arrangement, number of PCPs or propensity for quality of care for CDs (results not shown). Additionally, participating patients did not differ from non-participating ones regarding main diagnosis, age and gender (results not shown). Finally, prospective studies are needed that would have more information on clinical data (such as disease burden) and other patient characteristics (such as patient expectations) to better assess the impact of adding a specialist in co-management on ED use.

In terms of external validity, it is important to underline that the patients with arthritis probably had mainly osteoarthritis, which is the most frequent form of arthritis ([@R23]), and, therefore, our results may not be generalized to populations limited to inflammatory arthritis where specialist involvement is optimal ([@R21]; [@R45]). Furthermore, our participants came from practices formally providing services for CDs and had a regular PCP. Association between the type of specialist involvement and ED use may differ in patients followed in other practices or without a regular source of primary care.

Conclusion
==========

For patients living in the community with CDs and who were followed by their PCP, there was no difference in all-cause ED utilization between those with specialist involvement as a co-manager and those with consultant as a co-manager. The impact of the type of specialist involvement for patients with common CDs should be investigated with other outcomes (e.g., physiological, patient-reported or economic) to further understand indications for co-management. Nevertheless, overall specialist involvement regardless of its type tended to be associated with decreased risk of visiting the ED only for patients with COPD. Greater emphasis on coordination of care may be needed to prevent all-cause ED admission.
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